Canada markets closed

Moderna, Inc. (MRNA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
177.35-7.35 (-3.98%)
At close: 04:00PM EST
177.20 -0.15 (-0.08%)
After hours: 07:59PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close184.70
Open185.00
Bid177.20 x 1000
Ask177.50 x 900
Day's Range177.10 - 185.09
52 Week Range115.03 - 321.30
Volume3,497,758
Avg. Volume4,705,204
Market Cap68.134B
Beta (5Y Monthly)1.73
PE Ratio (TTM)6.19
EPS (TTM)28.63
Earnings DateFeb 22, 2023 - Feb 27, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est209.47
  • Yahoo Finance

    'Almost every health care company will be in the in cloud' in the next 10 years: AWS exec

    Cloud computing is not a new frontier in health care, but it is finally starting to bear some fruit, AWS exec Dr. Taha Kass-Hout, told Yahoo Finance.

  • Reuters

    U.S. CDC expands use of bivalent COVID vaccines for kids as young as 6 months

    The U.S. Centers for Disease Control and Prevention (CDC) on Friday expanded the use of COVID-19 vaccines that target both the original coronavirus and Omicron sub-variants to include children aged 6 months through 5 years. The development comes a day after the U.S. Food and Drug Administration authorized the updated shots from Moderna as well as Pfizer and its partner BioNTech for use in children as young as 6 months. Children aged 6 months through 5 years will now be eligible to get a Moderna bivalent booster 2 months after their final primary vaccination dose for COVID-19.

  • Zacks

    FDA Approves Pfizer, Moderna's Omicron COVID Jabs in Younger Kids

    Amid a rise in seasonal respiratory illnesses in younger children across the country, the FDA broadens the label of authorized bivalent Omicron BA.4/BA.5-adapted vaccines to include children as young as six months.